Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Paraneoplastic syndromes

J B Posner1, J Dalmau

  • 1Memorial Sloan-Kettering Cancer Center, Department of Neurology, New York, NY 10021, USA. posnerj@mskcc.org

Current Opinion in Immunology
|November 22, 1997
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Predicting the future of autoimmune encephalitides.

Revue neurologique·2024
Same author

The role of infections in autoimmune encephalitides.

Revue neurologique·2019
Same author

Iceberg sign as a dermoscopic clue of actinic keratosis neglecta.

Journal of the European Academy of Dermatology and Venereology : JEADV·2019
Same author

A Shiny Nodule on the Forehead of a Man.

Actas dermo-sifiliograficas·2019
Same author

[Autoimmune encephalitis].

Revista de neurologia·2018
Same author

Syndrome and outcome of antibody-negative limbic encephalitis.

European journal of neurology·2018
Same journal

A blind spot of human T cell immunology: epitope specificity in secondary lymphoid organs.

Current opinion in immunology·2026
Same journal

Germinal center responses at barrier organ sites.

Current opinion in immunology·2026
Same journal

Ocular sarcoidosis: from clinical signs to targeted interventions.

Current opinion in immunology·2026
Same journal

On or within: spatial determinants of antigen handling in the nasal turbinates.

Current opinion in immunology·2026
Same journal

Decoding the complexity of intestinal immunity with spatial transcriptomics.

Current opinion in immunology·2026
Same journal

Reconsidering the immunological aspects of solid-phase assays for antiphospholipid antibodies detection.

Current opinion in immunology·2026
See all related articles

Paraneoplastic neurological disorders are linked to autoimmune responses against cancer antigens like HuD. While anti-HuD antibodies show potential in cancer therapy, associated neurological issues currently limit their use in vaccines.

Area of Science:

  • Neuroimmunology
  • Oncology
  • Autoimmunity

Background:

  • Paraneoplastic syndromes involve organ disorders caused by cancer-triggered autoimmune responses.
  • Identified cancer antigens include Hu, Yo, and Ri proteins, with Hu antigens being extensively studied.
  • HuD antigen immunization in animals demonstrated neuroblastoma growth retardation.

Purpose of the Study:

  • To explore the potential of cancer antigens, particularly HuD, in cancer immunotherapy.
  • To investigate the clinical implications of anti-HuD antibodies in cancer patients.

Main Methods:

  • Review of existing research on paraneoplastic syndromes and cancer antigens.
  • Analysis of studies involving animal immunization with HuD.
  • Examination of clinical data correlating anti-HuD antibodies with tumor behavior.

Related Experiment Videos

Main Results:

  • Anti-HuD antibodies in small-cell lung cancer patients correlate with slower tumor growth.
  • HuD antigen-based immunization showed efficacy in retarding neuroblastoma growth in animal models.
  • Neurological complications associated with these autoimmune responses pose a challenge.

Conclusions:

  • HuD antigen and anti-HuD antibodies show promise as biomarkers and therapeutic targets in oncology.
  • The utility of HuD and similar antigens in cancer vaccines is currently limited by associated neurological disorders.
  • Further research is needed to overcome the neurotoxic effects for effective cancer immunotherapy.